Sato Ryota, Sanfilippo Filippo, Hasegawa Daisuke, Prasitlumkum Narut, Duggal Abhijit, Dugar Siddharth
Division of Critical Care Medicine, Department of Medicine, The Queen's Medical Center, Honolulu, HI, USA.
Department of Anaesthesia and Intensive Care, A.O.U. Policlinico-San Marco, Site "Policlinico G. Rodolico", Via S. Sofia N 78, 95123, Catania, Italy.
Ann Intensive Care. 2024 Feb 3;14(1):22. doi: 10.1186/s13613-024-01255-9.
The prevalence of hyperdynamic left ventricular (LV) systolic function in septic patients and its impact on mortality remain controversial. In this systematic review and meta-analysis, we investigated the prevalence and association of hyperdynamic LV systolic function with mortality in patients with sepsis.
We searched MEDLINE, Cochrane Central Register of Controlled Trials, and Embase. Primary outcomes were the prevalence of hyperdynamic LV systolic function in adult septic patients and the associated short-term mortality as compared to normal LV systolic function. Hyperdynamic LV systolic function was defined using LV ejection fraction (LVEF) of 70% as cutoff. Secondary outcomes were heart rate, LV end-diastolic diameter (LVEDD), and E/e' ratio.
Four studies were included, and the pooled prevalence of hyperdynamic LV systolic function was 18.2% ([95% confidence interval (CI) 12.5, 25.8]; I = 7.0%, P < 0.0001). Hyperdynamic LV systolic function was associated with higher mortality: odds ratio of 2.37 [95%CI 1.47, 3.80]; I = 79%, P < 0.01. No difference was found in E/e' (P = 0.43) between normal and hyperdynamic LV systolic function, while higher values of heart rate (mean difference: 6.14 beats/min [95%CI 3.59, 8.69]; I = 51%, P < 0.0001) and LVEDD (mean difference: - 0.21 cm [95%CI - 0.33, - 0.09]; I = 73%, P < 0.001) were detected in patients with hyperdynamic LV systolic function.
The prevalence of hyperdynamic LV systolic function is not negligible in septic patients. Such a finding is associated with significantly higher short-term mortality as compared to normal LV systolic function.
脓毒症患者高动力性左心室(LV)收缩功能的患病率及其对死亡率的影响仍存在争议。在这项系统评价和荟萃分析中,我们调查了脓毒症患者高动力性LV收缩功能的患病率及其与死亡率的关联。
我们检索了MEDLINE、Cochrane对照试验中央注册库和Embase。主要结局是成年脓毒症患者高动力性LV收缩功能的患病率以及与正常LV收缩功能相比的短期死亡率。高动力性LV收缩功能定义为LV射血分数(LVEF)≥70%。次要结局是心率、LV舒张末期内径(LVEDD)和E/e'比值。
纳入四项研究,高动力性LV收缩功能的合并患病率为18.2%([95%置信区间(CI)12.5,25.8];I² = 7.0%,P < 0.0001)。高动力性LV收缩功能与较高的死亡率相关:比值比为2.37 [95%CI 1.47,3.80];I² = 79%,P < 0.01。正常和高动力性LV收缩功能之间的E/e'无差异(P = 0.43),而高动力性LV收缩功能患者的心率较高(平均差异:6.14次/分钟 [95%CI 3.59,8.69];I² = 51%,P < 0.0001),LVEDD较高(平均差异: - 0.21 cm [95%CI - 0.33, - 0.09];I² = 73%,P < 0.001)。
脓毒症患者高动力性LV收缩功能的患病率不可忽视。与正常LV收缩功能相比,这一发现与显著更高的短期死亡率相关。